Keyphrases
Essential Tremor
100%
Movement Disorders
60%
Tremor
47%
Parkinson's Disease
41%
Non-invasive Neuromodulation
28%
Neuromodulation Therapy
28%
Home Monitoring
24%
Excessive Daytime Sleepiness
24%
Asterixis
24%
Transcutaneous Afferent Patterned Stimulation
24%
Rotigotine Patch
24%
MDSGene
24%
Rechargeable Implantable Pulse Generator
24%
Conversion Parameters
24%
Implanted Pulse Generator
24%
Phenomenology
24%
Tardive Dyskinesia
24%
Rotigotine
24%
Patients with Parkinson's Disease
24%
Parkinsonian Features
24%
Motor Symptoms
24%
Gabapentin
24%
Clinical Decision-making
24%
Dopamine Transporter Imaging
24%
Transdermal
24%
Home Use
24%
Wearable Devices
24%
Patient Satisfaction
24%
Deep Brain Stimulation
24%
Neuro-ophthalmology
24%
Episodic Ataxia
24%
Genotype-phenotype
24%
Use Studies
24%
Pathophysiology
20%
Flecainide
18%
Pathogenic Variants
18%
Parkinson Patients
17%
Clinical Trials
16%
Standardized Assessment
14%
Hand Tremor
14%
Kinesia
13%
Motion Sensor
13%
Tremor Assessment
13%
Placebo
12%
PDHA1
12%
SLC1A3
12%
Modafinil
12%
Epworth Sleepiness Scale
12%
Renal Disease
12%
KCNA1
12%
Medicine and Dentistry
Essential Tremor
75%
Stereotypic Movement Disorder
56%
Neuromodulation
32%
Parkinson's Disease
29%
Clinical Trial
27%
Clinician
26%
Patient Satisfaction
24%
Neuro-Ophthalmology
24%
Asterixis
24%
Deep Brain Stimulation
24%
Pulse Generator
24%
Home Monitoring
24%
Tardive Dyskinesia
24%
Gabapentin
24%
Clinical Decision Making
24%
Rotigotine
24%
Wearable Sensor
24%
Transdermal
24%
Real-World Evidence
24%
Quality of Life
21%
Hand Tremor
18%
Pathophysiology
17%
Adverse Event
15%
Side Effect
12%
Dystonia
9%
Unified Parkinson's Disease Rating Scale
9%
Akathisia
8%
Rating Scale
8%
Test Retest Reliability
8%
Health Care Personnel
8%
Patient-Reported Outcome
8%
Accelerometer
6%
Moderate Renal Impairment
6%
Neurotoxicity
6%